Meeting the Challenges of IBD Management in the Era of COVID-19: A Panel Case Review & Discussion

Program Overview

We have surveyed inflammatory bowel disease (IBD) providers around the country to find what cases they have struggled with when their patients with IBD concurrently developed COVID-19. In this activity, an IBD expert panel has been convened to discuss cases submitted by these physicians and answer questions such as, do biologics need to be interrupted? Do mRNA vaccines work when a patient is on a biologic? Do the COVID-19 vaccines cause IBD to flare? The panel takes on these timely questions and introduces you to a novel clinical decision support tool that you can access right now to help you assess your patients’ IBD complication risk and predict their response to biologics. The panel directly demonstrates how to utilize this free tool to manage IBD in these challenging cases, how your colleagues have been using it already, and how you can take advantage of it too.

Credit Expired
0.50 CE Credit(s)
Expires: January 3, 2023

Target Audience

This activity is intended for gastroenterology clinicians (MD/DO/NP/PA) and primary care clinicians involved in the care of patients with inflammatory bowel disease (IBD).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Stratify patients with inflammatory bowel disease (IBD) by disease severity and complication risk using predictive decision support tools
  • Implement personalized approaches to biologic therapies for patients with IBD based on probability of response to treatment
  • Identify patients with IBD at high risk of complications who may require treat-to-target monitoring or combination therapy

Activity Faculty


Parambir Dulai, MD (Chair)

Assistant Professor
UC San Diego School of Medicine
La Jolla, CA

Faculty-Kochhar-300x400px (1)

Gursimran Singh Kochhar, MD, FACP, CNSC

Associate Chief Division, Gastroenterology, Hepatology & Nutrition
Medical Director, Endoscopic Innovations AHN
Assistant Professor of Medicine, Drexel University
Interventional IBD & Therapeutic Endoscopy
Allegheny Health Network
Pittsburgh, PA

Faculty-Ungaro-300x400px (1)

Ryan Ungaro, MD, MS

Assistant Professor
The Susan and Leonard Feinstein IBD Center
Dr. Henry D. Janowitz Division of Gastroenterology
Icahn School of Medicine at Mount Sinai
New York, NY

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

© Copyright 2023. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | | (866) 770-RMEI


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources